Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | AGC family protein kinase | 0.0436 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0205 | 0.3065 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0205 | 0.3065 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0205 | 0.3065 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0205 | 0.3065 | 0.5 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0205 | 0.3065 | 0.5 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0205 | 0.3065 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Giardia lamblia | Kinase, NEK | 0.0436 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0205 | 0.3065 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Trichomonas vaginalis | STE family protein kinase | 0.0436 | 1 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0205 | 0.3065 | 0.5 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0205 | 0.3065 | 0.5 |
Toxoplasma gondii | NIMA-related protein kinase NIMA1 | 0.0436 | 1 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0205 | 0.3065 | 0.5 |
Plasmodium falciparum | NIMA related kinase 1 | 0.0436 | 1 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0205 | 0.3065 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0205 | 0.3065 | 0.3065 |
Giardia lamblia | Kinase, NEK | 0.0436 | 1 | 1 |
Plasmodium vivax | NIMA-related protein kinase (Pfnek-1), putative | 0.0436 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.07918 | Inhibition of COX2 in Homo sapiens (human) whole blood | ChEMBL. | No reference |
IC50 (binding) | = 1.2 nM | Inhibition of human COX2 in human whole blood | ChEMBL. | 18158247 |
IC50 (binding) | = 1.2 nM | Inhibition of human COX2 in human whole blood | ChEMBL. | 18158247 |
IC50 (binding) | = 1.2 nM | Inhibition of COX2 in Homo sapiens (human) whole blood | ChEMBL. | No reference |
Ratio IC50 (binding) | = 0.2 | Ratio of IC50 for COX2 in human whole blood to IC50 for human purified COX2 | ChEMBL. | 18158247 |
Ratio IC50 (binding) | = 0.2 | Ratio of IC50 for COX2 in human whole blood to IC50 for human purified COX2 | ChEMBL. | 18158247 |
Ratio IC50 (binding) | > 8403 | Ratio of IC50 for human COX1 to IC50 for human COX2 in human whole blood | ChEMBL. | 18158247 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.